WuXi Biologics (Cayman) Inc. (HKG:2269)
30.94
+0.12 (0.39%)
Aug 15, 2025, 4:08 PM HKT
WuXi Biologics Employees
WuXi Biologics had 12,575 employees as of December 31, 2024. The number of employees decreased by 165 or -1.30% compared to the previous year.
Employees
12,575
Change (1Y)
-165
Growth (1Y)
-1.30%
Revenue / Employee
1.58M HKD
Profits / Employee
284.01K HKD
Market Cap
125.94B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
BeOne Medicines | 11,000 |
Hansoh Pharmaceutical Group Company | 8,989 |
JD Health International | 3,564 |
Innovent Biologics | 5,659 |
Akeso | 3,035 |
Sino Biopharmaceutical | 24,379 |
CSPC Pharmaceutical Group | 21,400 |
Sichuan Kelun-Biotech Biopharmaceutical | 1,837 |
WuXi Biologics News
- 3 days ago - WuXi Biologics' WuXiUP™ Accomplishes Automated Continuous Drug Substance Production at Pilot-Scale - PRNewsWire
- 4 days ago - WuXi Biologics Launches HEK 293 Stable Cell Line Platform WuXia293 Stable for Development and Manufacturing of Difficult-to-Express Molecules - PRNewsWire
- 9 days ago - WuXi Biologics Named to A List for CDP Supplier Engagement Assessment - PRNewsWire
- 15 days ago - WuXi Biologics' Profit Guidance Signals Rebound In China's Drug Sector - Benzinga
- 15 days ago - WuXi Biologics' Profit Guidance Signals Rebound In China's Drug Sector - Benzinga
- 4 weeks ago - WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics - PRNewsWire
- 6 weeks ago - WuXi Biologics Launches Next-Generation Platform WuXiHigh™2.0 for High-Concentration Biologics with Protein Concentration Reaching 230 mg/mL - PRNewsWire
- 2 months ago - Focus: China pharma projects disrupted by Sino-US tensions - Reuters